SCHEMBL6093963

SCHEMBL6093963

C[C@@](N)(Cc1ccccc1)OS(=O)(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.50
TAAR1 Q96RJ0 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.46
HIF1A Q16665 1/20 0.46
MMP1 P03956 2/20 0.42
MMP9 P14780 2/20 0.42
MMP13 P45452 2/20 0.42
PTPN2 P17706 1/20 0.41
PTPN1 P18031 1/20 0.41
PTPRA P18433 1/20 0.41
PTPRB P23467 1/20 0.41
RECQL P46063 2/20 0.41
ALDH1A1 P00352 2/20 0.41
LMNA P02545 2/20 0.39
CYP2D6 P10635 1/20 0.39
CYP3A4 P08684 2/20 0.39
CYP1A2 P05177 1/20 0.39
BLM P54132 2/20 0.39
TRPA1 O75762 1/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1666735 1.00 SLC6A2 (0.50) SLC6A2TAAR1SMN1; SMN2HIF1AMMP1
SCHEMBL971950 0.84 SLC6A2 (0.52) SLC6A2TAAR1SMN1; SMN2HIF1AMMP1
SCHEMBL10661517 0.82 SMN1; SMN2 (0.48) SLC6A2TAAR1SMN1; SMN2HIF1AMMP1
Phentermine SCHEMBL28338903 0.78 SLC6A2 (0.76) SLC6A2TAAR1SMN1; SMN2HIF1AMMP1
SCHEMBL5465236 0.78 SLC6A2 (0.48) SLC6A2TAAR1SMN1; SMN2HIF1AMMP1
SCHEMBL4127162 0.77 PTPN2 (0.40) SLC6A2TAAR1SMN1; SMN2HIF1AMMP1
Sulfuric Acid SCHEMBL5465234 0.77 SLC6A2 (0.55) SLC6A2TAAR1SMN1; SMN2HIF1AMMP1
Phentermine SCHEMBL28815884 0.77 SLC6A2 (0.73) SLC6A2TAAR1SMN1; SMN2HIF1AMMP1
SCHEMBL10397637 0.75 PTPN2 (0.40) SLC6A2TAAR1SMN1; SMN2HIF1AMMP1
Ammonia Solution, Strong SCHEMBL340103 0.74 SLC6A2 (0.52) SLC6A2TAAR1SMN1; SMN2HIF1ARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7078565-B2 Benzamide derivatives as antagonists of orexin receptors SMITHKLINE BEECHAM PLC (GB) 2006-07-18 US disclosed
US-20050020584-A1 Benzamide derivatives as antagonists of orexin receptors SMITHKLINE BEECHAM P.L.C. (GB) 2005-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050020584-A1 Benzamide derivatives as antagonists of orexin receptors HCRTR2, HCRTR1, OXTR SLC6A2 630/4885TAAR1 154/4885SMN1; SMN2 3217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.